Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Fund Type: FCP
  • Objective: Health Care Sector
  • Asset Class: Equity
  • Geographic Focus: Global

UBS Lux Equity Fund - Health Care USD

+ Add to Watchlist

UBLLU:LX

254.1300 USD 0.00000.00%

As of 06:04:55 ET on 05/25/2015.

Snapshot for UBS Lux Equity Fund - Health Care USD (UBLLU)

Open: - High - Low: - Primary Exchange: Luxembourg
Volume: 0 52-Week Range: 202.0700 - 254.5500 Beta vs MXWO0HC: 0.8828

ETF Chart for UBLLU

No chart data available.
  • UBLLU:LX 254.1300
  • 1D
  • 1M
  • 1Y
254.1300
Interactive UBLLU Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Fund Profile & Information for UBLLU

UBS (Lux) Equity Fund - Health Care (USD) is an open-end investment fund incorporated in Luxembourg. The Fund invests globally in equities of large and medium-sized companies from the health care sector, which includes pharmaceuticals, biotechnology, hospital supplies, medical technology, and health care services.

Inception Date: Telephone: 352-44-10-10-1 Tel
Managers: SCOTT D WILKIN / IAN MCINTOSH
Web Site: www.ubs.com

Fundamentals for UBLLU

NAV -
Assets (M) (on 2015-05-22) 177.1974
Shares out (M) 0.00
Market Cap (M) 0.00
% Premium -
Average 52-Week % Premium -
Fund Leveraged N

Dividends for UBLLU

No dividends reported

Performance for UBLLU

1-Month +0.53% 1-Year +25.56%
3-Month +5.81% 3-Year +27.68%
Year To Date +13.92% 5-Year +18.88%
Expense Ratio 2.08

Top Fund Holdings for UBLLU

Filing Date: 03/31/2015
Name Position Value % of Total
Novartis AG 123,178 12,193,519 6.827%
Pfizer Inc 284,612 9,901,651 5.544%
UnitedHealth Group Inc 81,000 9,581,490 5.365%
Roche Holding AG 31,964 8,822,762 4.940%
Johnson & Johnson 77,400 7,786,440 4.359%
Actavis plc 24,500 7,291,690 4.082%
Eli Lilly & Co 96,400 7,003,460 3.921%
Novo Nordisk A/S 111,473 5,961,466 3.338%
Merck & Co Inc 97,712 5,616,486 3.145%
Impax Laboratories Inc 110,300 5,169,761 2.894%

Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil